Literature DB >> 20392986

Uterine artery embolization for leiomyomas: percentage of infarction predicts clinical outcome.

Thomas J Kroencke1, Christian Scheurig, Alexander Poellinger, Maike Gronewold, Bernd Hamm.   

Abstract

PURPOSE: To determine the effect of partial versus complete leiomyoma infarction on relief of leiomyoma-related symptoms and freedom from invasive reinterventions and to assess if patient age, location of the dominant leiomyoma, number of leiomyomas, or baseline uterine and dominant leiomyoma volume were associated with clinical failure.
MATERIALS AND METHODS: Study protocol was approved by the institutional review board, and informed consent was obtained. One hundred fifteen consecutive women (median age, 42 years; range, 34-61 years) with symptomatic uterine leiomyomas underwent contrast material-enhanced magnetic resonance (MR) imaging at baseline and 24-72 hours after uterine artery embolization (UAE) to determine the percentage of infarction of leiomyoma tissue (complete = 100%, almost complete = 90%-99%, and partial = 0%-89%). Clinical outcome and frequency of reinterventions were compared for up to 36 months.
RESULTS: One hundred thirteen patients completed at least one clinical follow-up. Twenty-four months after UAE, 50% +/- 15.2 (standard error) of the patients with partial infarction and 80% +/- 13.4 (standard error) of patients with almost complete infarction had undergone no reintervention. No patient with complete infarction needed a second treatment (P < .001). The hazard ratios for reintervention between the complete infarction group and the almost complete and partial infarction groups were 15.88 (95% confidence interval [CI]: 1.22, 2225.54; P = .034) and 73.08 (95% CI: 8.33, 9636.35; P < .001), respectively. There were significant differences in hazard ratios between patients with partial and those with complete infarction for persistence or recurrence of menorrhagia (hazard ratio, 7.45; 95% CI: 2.08, 28.31; P = .002) and bulk-related symptoms (hazard ratio, 5.90; 95% CI: 1.66, 21.92; P = .007). There was no significant correlation between patient age, number of leiomyomas, location of the dominant leiomyoma, or baseline uterine and dominant leiomyoma volume and clinical failure.
CONCLUSION: Women with leiomyoma infarction above 90% on contrast-enhanced MR images after UAE show significantly better symptom control and fewer reinterventions than do patients with a lower infarction rate. Copyright RSNA, 2010

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392986     DOI: 10.1148/radiol.10090977

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  15 in total

1.  Three-Dimensional Quantitative Assessment of Uterine Fibroid Response after Uterine Artery Embolization Using Contrast-Enhanced MR Imaging.

Authors:  Julius Chapiro; Rafael Duran; MingDe Lin; John D Werner; Zhijun Wang; Rüdiger Schernthaner; Lynn Jeanette Savic; Mark L Lessne; Jean-François Geschwind; Kelvin Hong
Journal:  J Vasc Interv Radiol       Date:  2015-01-28       Impact factor: 3.464

2.  Uterine artery embolization by use of porous gelatin particles for symptomatic uterine leiomyomas: comparison with hand-cut gelatin sponge particles.

Authors:  Yuichiro Izumi; Shuji Ikeda; Akira Kitagawa; Eisuke Katsuda; Makiyo Hagihara; Seiji Kamei; Toyohiro Ota; Tsuneo Ishiguchi
Journal:  Jpn J Radiol       Date:  2015-06-23       Impact factor: 2.374

Review 3.  The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy.

Authors:  Reshef Tal; James H Segars
Journal:  Hum Reprod Update       Date:  2013-09-29       Impact factor: 15.610

4.  Three-dimensional quantitative assessment of lesion response to MR-guided high-intensity focused ultrasound treatment of uterine fibroids.

Authors:  Lynn J Savic; Ming De Lin; Rafael Duran; Rüdiger E Schernthaner; Bernd Hamm; Jean-François Geschwind; Kelvin Hong; Julius Chapiro
Journal:  Acad Radiol       Date:  2015-07-07       Impact factor: 3.173

5.  Prediction of early response to uterine arterial embolisation of adenomyosis: value of T2 signal intensity ratio of adenomyosis.

Authors:  Dae Chul Jung; Man Deuk Kim; Young Taik Oh; Jong Yun Won; Do Yun Lee
Journal:  Eur Radiol       Date:  2012-04-17       Impact factor: 5.315

6.  Can measurement of apparent diffusion coefficient before treatment predict the response to uterine artery embolization for adenomyosis?

Authors:  Yaewon Park; Man Deuk Kim; Dae Chul Jung; Shin Jae Lee; Gyoungmin Kim; Sung Il Park; Jong Yun Won; Do Yun Lee
Journal:  Eur Radiol       Date:  2014-12-07       Impact factor: 5.315

7.  Diffusion-weighted MR imaging of uterine leiomyomas following uterine artery embolization.

Authors:  Olivier Sutter; Philippe Soyer; Eimad Shotar; Raphael Dautry; Youcef Guerrache; Vinciane Placé; Raluca Opréa; Aude Ricbourg; Olivier Le Dref; Mourad Boudiaf; Marc Sirol; Anthony Dohan
Journal:  Eur Radiol       Date:  2016-01-22       Impact factor: 5.315

8.  Low vascularity predicts favourable outcomes in leiomyoma patients treated with uterine artery embolization.

Authors:  Yixin Tang; Chunlin Chen; Hui Duan; Ben Ma; Ping Liu
Journal:  Eur Radiol       Date:  2016-01-27       Impact factor: 5.315

9.  Predisposing factors for predicting the therapeutic response of adenomyosis after uterine artery embolization: serum CA125 levels and accompanying endometriosis.

Authors:  Rui Zheng; Dan Zeng; Ting-Ting Wan; Wen-Bo Guo; Yan Guo; Ming-Juan Liu
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

10.  Uterine and Fibroid Imaging Analysis from the FIRSTT Study.

Authors:  Shannon K Laughlin-Tommaso; Krzysztof R Gorny; Gina K Hesley; Lisa E Vaughan; David A Woodrum; Maureen A Lemens; Elizabeth A Stewart
Journal:  J Womens Health (Larchmt)       Date:  2021-07-08       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.